Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Cytokines be Used as an Activation Marker in Rheumatoid Arthritis

NCT04486027 is registered in ClinicalTrials.gov with Maltepe University as lead sponsor.

NCT NCT04486027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04486027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Cytokines be Used as an Activation Marker in Rheumatoid Arthritis
Lead sponsor
Maltepe University
Phase
Observational
Overall status
Completed
Start date
April 5, 2017
Completion date
December 15, 2018
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis